These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27716592)

  • 21. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB
    Med Clin North Am; 1990 Jan; 74(1):133-53. PubMed ID: 2404172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease.
    Brzezinski A; Rankin GB; Seidner DL; Lashner BA
    Cleve Clin J Med; 1995; 62(5):317-23. PubMed ID: 7586488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice.
    Li YH; Zhang M; Xiao HT; Fu HB; Ho A; Lin CY; Huang Y; Lin G; Bian ZX
    PLoS One; 2015; 10(12):e0144101. PubMed ID: 26642326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
    Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a colon delivery capsule to 5-aminosalicylic acid and evaluation of the pharmacokinetic profile after oral administration to beagle dogs.
    Takaya T; Sawada K; Suzuki H; Funaoka A; Matsuda K; Takada K
    J Drug Target; 1997; 4(5):271-6. PubMed ID: 9169983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.
    Mahmud N; Weir DG; Kelleher D
    Ir J Med Sci; 1999; 168(4):228-32. PubMed ID: 10624358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
    D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
    FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Bhatt L; Vadnerkar G; Kadam SS
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1897-902. PubMed ID: 17280832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
    Sutherland LR; May GR; Shaffer EA
    Ann Intern Med; 1993 Apr; 118(7):540-9. PubMed ID: 8095128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine.
    Axelsson LG; Landström E; Bylund-Fellenius AC
    Aliment Pharmacol Ther; 1998 Sep; 12(9):925-34. PubMed ID: 9768537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory bowel disease.
    Van Rosendaal GM
    CMAJ; 1989 Jul; 141(2):113-23; discussion 123-4. PubMed ID: 2568163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.
    Sarkate A; Dhaneshwar SS
    World J Gastroenterol; 2017 Feb; 23(7):1147-1162. PubMed ID: 28275295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Aminosalicylic acid, a specific drug for ulcerative colitis.
    Hauso Ø; Martinsen TC; Waldum H
    Scand J Gastroenterol; 2015 Aug; 50(8):933-41. PubMed ID: 25733192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New light on the anti-colitic actions of therapeutic aminosalicylates: the role of heme oxygenase.
    Whittle BJ; Varga C
    Pharmacol Rep; 2010; 62(3):548-56. PubMed ID: 20631420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease.
    Robinson MG
    Gastroenterol Clin North Am; 1989 Mar; 18(1):43-50. PubMed ID: 2646221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat.
    Gálvez J; Garrido M; Merlos M; Torres MI; Zarzuelo A
    Br J Pharmacol; 2000 Aug; 130(8):1949-59. PubMed ID: 10952687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.